vesicare solifenacin succinate 5 mg

1 INDICATIONS AND USAGE VESIcare ® is indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. VESIcare is a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )

astellas pharma us, inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] nausea` `[4] diarrhoea` `[5] fatigue` `[6] vomiting` `[7] dyspnoea` `[8] seizure` `[9] pyrexia` `[10] death`

6 years ago

ROUND YELLOW 150

16 HOW SUPPLIED/STORAGE AND HANDLING VESIcare is supplied as round, film-coated tablets, available in bottles as follows: Each 5 mg tablet is light yellow and debossed with a logo and “150” and is available as follows: Bottle of 30 NDC 51248-150-01 Each 10 mg tablet is light pink and debossed with a logo and “151” and is available as follows: Bottle of 30 NDC 51248-151-01 Bottle of 90 NDC 51248-151-03 Store at 25°C (77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].

More pills like ROUND 150

Related Pills

solifenacin succinate 10 mg

astellas pharma us, inc.

solifenacin succinate 10 mg

astellas pharma us, inc.

solifenacin succinate 5 mg VESICARE

Astellas Pharma Technologies, Inc.

ranitidine 150 MG as ranitidine hydrochloride 168 MG Oral Tablet

Dr. Reddy's Laboratories Limited

ranitidine hydrochloride tablet

Lyrica 150 MG Oral Capsule

Parke-Davis Div of Pfizer Inc

Lyrica 150 MG Oral Capsule

pd-rx pharmaceuticals, inc.

omeprazole 20 MG Delayed Release Capsule

Mylan Pharmaceuticals Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site